Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12024528 Bridged tricyclic carbamoylpyridone compounds and uses thereof

Patent 12024528 was granted and assigned to Gilead Sciences on July, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Gilead Sciences

0

Current Assignee

Gilead Sciences

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Jiayao Li0

Anna E. Hurtley0

Gregg M. Schwarzwalder0

Lan Jiang0

Matthew J. Von Bargen0

Ana Z. Gonzalez Buenrostro0

Devleena M. Shivakumar0

Qiaoyin Wu0

...

Date of Patent

July 2, 2024

0

Patent Application Number

183346110

Date Filed

June 14, 2023

0

Patent Citations

US Patent 11697652 Tetracyclic compounds and uses thereof

0

US Patent 11884683 Tricyclic heterocycle compounds useful as HIV integrase inhibitors

0

US Patent 9522912 Polycyclic-carbamoylpyridone compounds and their pharmaceutical use

0

US Patent 10087178 Substituted spiropyrido[1,2-a]pyrazine derivative and medicinal use thereof as HIV integrase inhibitor

0

US Patent 11084832 Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use

0

US Patent 11492352 Arenavirus growth inhibitor comprising polycyclic carbamoylpyridone derivative

0

US Patent 11548902 Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use

0

Patent Citations Received

US Patent 12122776 Tetracyclic compounds and uses thereof

0

Patent Primary Examiner

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12024528 Bridged tricyclic carbamoylpyridone compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool